Anti HSC70 pAb (Rabbit)

Research Area/Plants & Arthropods & Fungi/Arabidopsis thaliana/Primary Antibodies; Antibodies/Primary Antibodies/Chaperones; Antibodies/Chaperones/Primary Antibodies; Research Area/Cell Biology/Chaperones/Primary Antibodies; Research Area/Cell Biology/Apoptosis/Primary Antibodies; Research Area/Cell Biology/Autophagy/Primary Antibodies; Research Area/Cell Biology/Cell Cycle/Primary Antibodies; Research Area/Cell Biology/Cell Differentiation/Primary Antibodies; Research Area/Cell Biology/Cell Growth/Primary Antibodies; Research Area/Cell Biology/Cell Metabolism/Primary Antibodies; Research Area/Cell Biology/Gene Expression & Transcription/Primary Antibodies; Research Area/Cell Biology/Heat Shock/Primary Antibodies; Research Area/Cell Biology/Protein Folding/Primary Antibodies; Research Area/Cell Biology/RNA Processing/Primary Antibodies; Research Area/Cell Biology/RNA Splicing/Primary Antibodies; Research Area/Cell Biology/Senescence/Primary Antibodies; Research Area/Cell Biology/Signal Transduction/Primary Antibodies; Research Area/Cell Biology/Ubiquitin-SUMO-Proteasome related/Primary Antibodies; Research Area/Cell Biology/Unfolded Protein Response/Primary Antibodies; Research Area/Cell Biology/Vesicular Biogenesis & Trafficking/Primary Antibodies; Research Area/Disease/Alzheimer's Disease/Primary Antibodies; Research Area/Disease/Breast Cancer/Primary Antibodies; Research Area/Disease/Colorectal Cancer/Primary Antibodies; Research Area/Disease/Gastric Cancer/Primary Antibodies; Research Area/Disease/Hepatocellular Carcinoma/Primary Antibodies; Research Area/Disease/Huntington Disease/Primary Antibodies; Research Area/Disease/Lung Cancer/Primary Antibodies; Research Area/Disease/Parkinson Disease/Primary Antibodies; Research Area/Immunology & Inflammation/Antigen Processing & Presentation/Primary Antibodies; Research Area/Disease/Schizophrenia/Primary Antibodies; Research Area/Disease/Spinocerebellar Ataxia/Primary Antibodies; Research Area/Immunology & Inflammation/Innate Immunity/Primary Antibodies; Research Area/Neurobiology/Neurodegeneration/Primary Antibodies; Research Area/Oncology/Diagnostics & Biomarkers/Primary Antibodies; Research Area/Organelles & Subcellular Structures/Spliceosome/Primary Antibodies; Research Area/Systemic Physiology/Aging/Primary Antibodies

General information: Each antibody was raised in rabbits against the corresponding synthetic peptide or the purified enzyme. Therefore, Protein A or
anti-(rabbit IgG) antibodies can be used as the second antibodies for immunoblotting.
Sample treatment: Please do not boil the protein or membrane samples for immunoblotting. We recommend the treatment at 70°C for 10 min.
Sample amount: For the major component of membranes, such as acuolar and plasma membrane aquaporins (TIPsand PIPs) and H+-pyrophosphatase, a small amount of the crude membrane fraction (a few micrograms) is enough to detect the antigen protein. When you use the purified preparation of vacuolar and plasma membranes, the antibodies can detect the antigenprotein in one microgram membrane preparation.
Antibody dilution: Please dilute the antibody solution to 1:2000 or more with TBS (Tris-buffered saline) or PBS (phosphate-buffered saline), if you use the ECL
detection system. For example, 5 uL of the original antibody solution can be diluted with 10 mL of TBS. The diluted antibody solutions can be used twice or three times within a month. In this case, please add sodium azide into the antibody solution at 0.05% before the first experiment and store at 20°C or 80°C.
Second antibodies: We recommend HRP-linkd Protein A and HRP-linked anti-(rabbit IgG) antibodies. Please dilute the second antibody to 1:3000 with TBS or PBS.
Antigen detection: We recommend the ECL detection system for immunoblotting, because its sensitivity is high and you can select the best expose period for
detection of the antigen.

Polyclonal